
FASN Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application
Description
FASN Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application
This report describes the global market size of FASN Inhibitor from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030.
For geography segment, regional supply, demand, major players, price is presented from 2020 to 2030. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of FASN Inhibitor as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share
Applications Segment:
Liver diseases
Cancer
Companies Covered:
Akero Therapeutics Inc.
Bristol-Myers Squibb
CymaBay Therapeutics Inc.
Enanta Pharmaceuticals Inc.
Galmed Pharmaceuticals Ltd.
Gilead Sciences
Intercept Pharmaceuticals Inc.
Inventiva S.A.
Madrigal Pharmaceuticals Inc.
Metacrine
NGM Biopharmaceuticals Inc.
Novartis
Pfizer
etc.
Please ask for sample pages for full companies list
Base Year: 2025
Historical Data: from 2020 to 2024
Forecast Data: from 2025 to 2030
Table of Contents
118 Pages
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- 5.6 Covid-19 Impact
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Fasn Inhibitor Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Fasn Inhibitor Market in North America (2020-2030)
- 8.1 Fasn Inhibitor Market Size
- 8.2 Fasn Inhibitor Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Fasn Inhibitor Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Fasn Inhibitor Market in South America (2020-2030)
- 9.1 Fasn Inhibitor Market Size
- 9.2 Fasn Inhibitor Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Fasn Inhibitor Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Fasn Inhibitor Market in Asia & Pacific (2020-2030)
- 10.1 Fasn Inhibitor Market Size
- 10.2 Fasn Inhibitor Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Fasn Inhibitor Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Fasn Inhibitor Market in Europe (2020-2030)
- 11.1 Fasn Inhibitor Market Size
- 11.2 Fasn Inhibitor Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Fasn Inhibitor Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Fasn Inhibitor Market in MEA (2020-2030)
- 12.1 Fasn Inhibitor Market Size
- 12.2 Fasn Inhibitor Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Fasn Inhibitor Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Fasn Inhibitor Market (2020-2025)
- 13.1 Fasn Inhibitor Market Size
- 13.2 Fasn Inhibitor Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Fasn Inhibitor Market Size by Type
- Chapter 14 Global Fasn Inhibitor Market Forecast (2025-2030)
- 14.1 Fasn Inhibitor Market Size Forecast
- 14.2 Fasn Inhibitor Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Fasn Inhibitor Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 Akero Therapeutics Inc.
- 15.1.1 Company Profile
- 15.1.2 Main Business and FASN Inhibitor Information
- 15.1.3 SWOT Analysis of Akero Therapeutics Inc.
- 15.1.4 Akero Therapeutics Inc. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 Bristol-Myers Squibb
- 15.2.1 Company Profile
- 15.2.2 Main Business and FASN Inhibitor Information
- 15.2.3 SWOT Analysis of Bristol-Myers Squibb
- 15.2.4 Bristol-Myers Squibb FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 CymaBay Therapeutics Inc.
- 15.3.1 Company Profile
- 15.3.2 Main Business and FASN Inhibitor Information
- 15.3.3 SWOT Analysis of CymaBay Therapeutics Inc.
- 15.3.4 CymaBay Therapeutics Inc. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 Enanta Pharmaceuticals Inc.
- 15.4.1 Company Profile
- 15.4.2 Main Business and FASN Inhibitor Information
- 15.4.3 SWOT Analysis of Enanta Pharmaceuticals Inc.
- 15.4.4 Enanta Pharmaceuticals Inc. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.5 Galmed Pharmaceuticals Ltd.
- 15.5.1 Company Profile
- 15.5.2 Main Business and FASN Inhibitor Information
- 15.5.3 SWOT Analysis of Galmed Pharmaceuticals Ltd.
- 15.5.4 Galmed Pharmaceuticals Ltd. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.6 Gilead Sciences
- 15.6.1 Company Profile
- 15.6.2 Main Business and FASN Inhibitor Information
- 15.6.3 SWOT Analysis of Gilead Sciences
- 15.6.4 Gilead Sciences FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.7 Intercept Pharmaceuticals Inc.
- 15.7.1 Company Profile
- 15.7.2 Main Business and FASN Inhibitor Information
- 15.7.3 SWOT Analysis of Intercept Pharmaceuticals Inc.
- 15.7.4 Intercept Pharmaceuticals Inc. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.8 Inventiva S.A.
- 15.8.1 Company Profile
- 15.8.2 Main Business and FASN Inhibitor Information
- 15.8.3 SWOT Analysis of Inventiva S.A.
- 15.8.4 Inventiva S.A. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.9 Madrigal Pharmaceuticals Inc.
- 15.9.1 Company Profile
- 15.9.2 Main Business and FASN Inhibitor Information
- 15.9.3 SWOT Analysis of Madrigal Pharmaceuticals Inc.
- 15.9.4 Madrigal Pharmaceuticals Inc. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.10 Metacrine
- 15.10.1 Company Profile
- 15.10.2 Main Business and FASN Inhibitor Information
- 15.10.3 SWOT Analysis of Metacrine
- 15.10.4 Metacrine FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.11 NGM Biopharmaceuticals Inc.
- 15.11.1 Company Profile
- 15.11.2 Main Business and FASN Inhibitor Information
- 15.11.3 SWOT Analysis of NGM Biopharmaceuticals Inc.
- 15.11.4 NGM Biopharmaceuticals Inc. FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.12 Novartis
- 15.12.1 Company Profile
- 15.12.2 Main Business and FASN Inhibitor Information
- 15.12.3 SWOT Analysis of Novartis
- 15.12.4 Novartis FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- 15.13 Pfizer
- 15.13.1 Company Profile
- 15.13.2 Main Business and FASN Inhibitor Information
- 15.13.3 SWOT Analysis of Pfizer
- 15.13.4 Pfizer FASN Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Fasn Inhibitor Report
- Table Data Sources of Fasn Inhibitor Report
- Table Major Assumptions of Fasn Inhibitor Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Fasn Inhibitor Picture
- Table Fasn Inhibitor Classification
- Table Fasn Inhibitor Applications
- Table Drivers of Fasn Inhibitor Market
- Table Restraints of Fasn Inhibitor Market
- Table Opportunities of Fasn Inhibitor Market
- Table Threats of Fasn Inhibitor Market
- Table Covid-19 Impact For Fasn Inhibitor Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Fasn Inhibitor
- Table Cost Structure Analysis of Fasn Inhibitor
- Table Key End Users
- Table Latest News of Fasn Inhibitor Market
- Table Merger and Acquisition
- Table Planned/Future Project of Fasn Inhibitor Market
- Table Policy of Fasn Inhibitor Market
- Table 2020-2030 North America Fasn Inhibitor Market Size
- Figure 2020-2030 North America Fasn Inhibitor Market Size and CAGR
- Table 2020-2030 North America Fasn Inhibitor Market Size by Application
- Table 2020-2025 North America Fasn Inhibitor Key Players Revenue
- Table 2020-2025 North America Fasn Inhibitor Key Players Market Share
- Table 2020-2030 North America Fasn Inhibitor Market Size by Type
- Table 2020-2030 United States Fasn Inhibitor Market Size
- Table 2020-2030 Canada Fasn Inhibitor Market Size
- Table 2020-2030 Mexico Fasn Inhibitor Market Size
- Table 2020-2030 South America Fasn Inhibitor Market Size
- Figure 2020-2030 South America Fasn Inhibitor Market Size and CAGR
- Table 2020-2030 South America Fasn Inhibitor Market Size by Application
- Table 2020-2025 South America Fasn Inhibitor Key Players Revenue
- Table 2020-2025 South America Fasn Inhibitor Key Players Market Share
- Table 2020-2030 South America Fasn Inhibitor Market Size by Type
- Table 2020-2030 Brazil Fasn Inhibitor Market Size
- Table 2020-2030 Argentina Fasn Inhibitor Market Size
- Table 2020-2030 Chile Fasn Inhibitor Market Size
- Table 2020-2030 Peru Fasn Inhibitor Market Size
- Table 2020-2030 Asia & Pacific Fasn Inhibitor Market Size
- Figure 2020-2030 Asia & Pacific Fasn Inhibitor Market Size and CAGR
- Table 2020-2030 Asia & Pacific Fasn Inhibitor Market Size by Application
- Table 2020-2025 Asia & Pacific Fasn Inhibitor Key Players Revenue
- Table 2020-2025 Asia & Pacific Fasn Inhibitor Key Players Market Share
- Table 2020-2030 Asia & Pacific Fasn Inhibitor Market Size by Type
- Table 2020-2030 China Fasn Inhibitor Market Size
- Table 2020-2030 India Fasn Inhibitor Market Size
- Table 2020-2030 Japan Fasn Inhibitor Market Size
- Table 2020-2030 South Korea Fasn Inhibitor Market Size
- Table 2020-2030 Southeast Asia Fasn Inhibitor Market Size
- Table 2020-2030 Australia Fasn Inhibitor Market Size
- Table 2020-2030 Europe Fasn Inhibitor Market Size
- Figure 2020-2030 Europe Fasn Inhibitor Market Size and CAGR
- Table 2020-2030 Europe Fasn Inhibitor Market Size by Application
- Table 2020-2025 Europe Fasn Inhibitor Key Players Revenue
- Table 2020-2025 Europe Fasn Inhibitor Key Players Market Share
- Table 2020-2030 Europe Fasn Inhibitor Market Size by Type
- Table 2020-2030 Germany Fasn Inhibitor Market Size
- Table 2020-2030 France Fasn Inhibitor Market Size
- Table 2020-2030 United Kingdom Fasn Inhibitor Market Size
- Table 2020-2030 Italy Fasn Inhibitor Market Size
- Table 2020-2030 Spain Fasn Inhibitor Market Size
- Table 2020-2030 Belgium Fasn Inhibitor Market Size
- Table 2020-2030 Netherlands Fasn Inhibitor Market Size
- Table 2020-2030 Austria Fasn Inhibitor Market Size
- Table 2020-2030 Poland Fasn Inhibitor Market Size
- Table 2020-2030 Russia Fasn Inhibitor Market Size
- Table 2020-2030 MEA Fasn Inhibitor Market Size
- Figure 2020-2030 MEA Fasn Inhibitor Market Size and CAGR
- Table 2020-2030 MEA Fasn Inhibitor Market Size by Application
- Table 2020-2025 MEA Fasn Inhibitor Key Players Revenue
- Table 2020-2025 MEA Fasn Inhibitor Key Players Market Share
- Table 2020-2030 MEA Fasn Inhibitor Market Size by Type
- Table 2020-2030 Egypt Fasn Inhibitor Market Size
- Table 2020-2030 Israel Fasn Inhibitor Market Size
- Table 2020-2030 South Africa Fasn Inhibitor Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Fasn Inhibitor Market Size
- Table 2020-2030 Turkey Fasn Inhibitor Market Size
- Table 2020-2025 Global Fasn Inhibitor Market Size by Region
- Table 2020-2025 Global Fasn Inhibitor Market Size Share by Region
- Table 2020-2025 Global Fasn Inhibitor Market Size by Application
- Table 2020-2025 Global Fasn Inhibitor Market Share by Application
- Table 2020-2025 Global Fasn Inhibitor Key Vendors Revenue
- Figure 2020-2025 Global Fasn Inhibitor Market Size and Growth Rate
- Table 2020-2025 Global Fasn Inhibitor Key Vendors Market Share
- Table 2020-2025 Global Fasn Inhibitor Market Size by Type
- Table 2020-2025 Global Fasn Inhibitor Market Share by Type
- Table 2025-2030 Global Fasn Inhibitor Market Size by Region
- Table 2025-2030 Global Fasn Inhibitor Market Size Share by Region
- Table 2025-2030 Global Fasn Inhibitor Market Size by Application
- Table 2025-2030 Global Fasn Inhibitor Market Share by Application
- Table 2025-2030 Global Fasn Inhibitor Key Vendors Revenue
- Figure 2025-2030 Global Fasn Inhibitor Market Size and Growth Rate
- Table 2025-2030 Global Fasn Inhibitor Key Vendors Market Share
- Table 2025-2030 Global Fasn Inhibitor Market Size by Type
- Table 2025-2030 Fasn Inhibitor Global Market Share by Type
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.